19 July 2024
The Prime Minister of the Russian Federation, Mikhail Mishustin, has signed a decree to ease the conditions for receiving compensation for doctors who opt to participate in the “Zemsky Doctor” or “Zemsky Paramedic” program. Health workers with higher and secondary education, who have entered into agreements to receive a one-time compensation payment for relocating to rural areas, now have the privilege of changing their place of employment without forfeiting the subsidy.
However, this can only be done within the same region. In the past, health workers were required to enter into an agreement with a medical institution in order to receive state support, committing to work there for at least five years.
Furthermore, the compensation for doctors, paramedics, midwives, and nurses who choose to reside and serve in rural communities, workers’ settlements, or urban-like settlements in the Far East, the Far North, and the Arctic has been raised to 2 million and 1 million rubles respectively – effectively doubling their previous remuneration.
The government would like to remind everyone that moving from the city to the countryside is not a mandatory condition for receiving the payment. Graduates of medical colleges and universities who have successfully completed their studies and returned to their local communities, where they are registered as residents, can rely on state support.
In 2024, the federal budget is committed to allocating approximately 6 billion rubles to compensate health professionals through the Zemsky Doctor and Zemsky Paramedic programs. Compensations are provided within the framework of the state program “Health Development”.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
Novel nanoemulsion-based delivery of antimycobacterial drug
31 October 2024
Russia will create a National Center for Genetic Resources of Microorganisms
31 October 2024
Optimising drug release of personalised 3D printed tablets
30 October 2024
Immunotherapy treatment enhances lymphoma survival, landmark study shows
30 October 2024